Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor

被引：0
|
作者：
Tomer, Mark [1 ]
Lucio, Gordan [2 ]
David, Ray [1 ]
Stephen, Ijioma [1 ]
George, Dranitsaris [3 ]
Amanda, Warner [2 ]
Trevor, Heritage [2 ]
Matthew, Fink [2 ]
David, Wenk [2 ]
Shachar, Peles [2 ]
机构：
[1] Karyopharm Therapeut Inc, Newton, MA USA
[2] Florida Canc Specialists & Res Inst, Tampa, FL USA
[3] Syracuse Univ, Dept Publ Hlth, Syracuse, NY USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-038
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [1] Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor
    Gordan, Lucio N.
    Ray, David
    Ijioma, Stephen C.
    Dranitsaris, George
    Warner, Amanda
    Heritage, Trevor
    Fink, Matthew
    Wenk, David
    Chadwick, Paul
    Khrystolubova, Natasha
    Peles, Shachar
    [J]. CURRENT ONCOLOGY, 2024, 31 (01) : 501 - 510
  • [2] Selinexor for the treatment of patients with relapsed or refractory multiple myeloma
    Babar, Anum
    Babar, Maham
    Zubair, Hina
    Shahid, Arzu
    Rafique, Sana
    Bano, Maimona
    Waleed, Madeeha Subhan
    Khan, Maimoona
    Inayat, Arslan
    Safi, Danish
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (03) : 535 - 546
  • [3] Selinexor in relapsed/refractory multiple myeloma
    Richter, Joshua
    Madduri, Deepu
    Richard, Shambavi
    Chari, Ajai
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [4] SYMPTOM MANAGEMENT FOR PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA RECEIVING THERAPY WITH SELINEXOR (XPOVIO™)
    Florendo, Erika
    Mancia, Ines Stefania
    Thomas, Joanne
    [J]. ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [5] Clinical impact of time to the best response in relapsed/refractory multiple myeloma patients receiving carfilzomib
    Cho, Hee Jeong
    Moon, Joon Ho
    Kim, Ju-Hyung
    Baek, Dong Won
    Sohn, Sang-Kyun
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S166 - S166
  • [6] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [7] Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
    Gasparetto, Cristina
    Lentzsch, Suzanne
    Schiller, Gary
    Callander, Natalie
    Tuchman, Sascha
    Chen, Christine
    White, Darrell
    Kotb, Rami
    Sutherland, Heather
    Sebag, Michael
    Baljevic, Muhamed
    Bensinger, William
    Leblanc, Richard
    Venner, Chris
    Bahlis, Nizar
    Rossi, Adriana
    Biran, Noa
    Sheehan, Heidi
    Saint-Martin, Jean-Richard
    Van Domelen, Dane
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael
    Lipe, Brea
    [J]. EJHAEM, 2021, 2 (01): : 56 - 65
  • [8] US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma
    Bassali, Jan
    Gould, Ian Gopal
    Kaye, James A.
    Mladsi, Deirdre
    Mehta, Jyotsna
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 317 - 325
  • [9] Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).
    Gasparetto, Cristina
    Lentzsch, Suzanne
    Schiller, Gary J.
    Callander, Natalie Scott
    Tuchman, Sascha
    Bahlis, Nizar J.
    White, Darrell
    Chen, Christine
    Baljevic, Muhamed
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Bensinger, William
    Rossi, Adriana C.
    Sheehan, Heidi
    Arazy, Melina
    Kai, Kazuharu
    Lipe, Brea
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Selinexor, Pomalidomide, and Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Christine I.
    Bahlis, Nizar
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea C.
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    Leblanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie Scott
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    [J]. BLOOD, 2019, 134
12345